ADHD burden
ADHD can be a lot to handle
Along with ADHD diagnostic symptoms* of inattention and hyperactivity/impulsivity, associated features—such as emotional dysregulation and executive dysfunction—may also impact patients.1,2 When these challenges stack up, especially alongside comorbidities, patients may be left with unaddressed needs.
Actor portrayal
false
72
40
0
See how these ADHD challenges can stack up
center
font-weight-extrabold
32
32
0
100%
20px
16px
center
59% of treated adults with ADHD still report difficulties in sustaining attention and concentration.1
custom
inline-padding,disable-texture
center
Even with treatment, many patients with ADHD continue[br-d] to experience some[br-d] symptoms, which can include emotional dysregulation (45%) and executive dysfunction (37%).1,3
inline-padding,disable-texture
32
32
0
32
32
0
*Diagnostic symptoms are included in the DSM-5-TR diagnostic criteria. Associated features are separate from diagnostic symptoms but support a diagnosis of ADHD and can exacerbate the impairment patients already face with ADHD.
text-brand-navy
font-weight-medium
size-website-caption
link-underline-red
104
72
0
THE SCIENCE OF ADHD
center
text-brand-orange
font-weight-extrabold
site-eyebrow
Multiple neurotransmitters[br-m] may play a role in[br-d] ADHD symptoms4,8,9
center
text-brand-navy
font-weight-extrabold
site-h1
24
24
0
custom
2.45fr 1fr
1
custom
20px
stretch
879px / 355px
center
false
104
72
0
yellow
Treat adhd differently
Discover the trio in action
The interplay among these 3 neurotransmitters—norepinephrine, dopamine, serotonin—[br-d]may be responsible for the distinct mix of diagnostic symptoms and associated[br-d] features in each patient.4,8,9
button
left-right
full-width
104
72
0
custom
2.23fr 4.01fr
1
custom
110px
custom
32px
stretch
1060px / 900px / 355px
center
false
104
72
0
24
24
0
false
default
REFERENCES
- Brown TE, et al. The patient perspective: unmet treatment needs in adults with attention-deficit/hyperactivity disorder. Prim Care[br-m] Companion CNS Disord. 2019;21(3):18m02397.
- American Psychiatric Association. Diagnostic[br-m] and Statistical Manual of Mental Disorders. Fifth[br-m]Edition, Text Revision. DSM-5-TR™. American[br] Psychiatric Publishing; 2022.
- Schein J, et al. Symptoms associated with ADHD/treatment-related adverse side effects[br-m]and their impact on quality of life and work productivity[br-d] in adults with ADHD. Curr Med Res[br-m] Opin. 2023;39(1):149-159.
- Shaw P, et al. Emotion dysregulation in[br-m]attention deficit hyperactivity disorder. Am J Psychiatry. 2014;171(3):276-293.
- Kessler RC, et al. The prevalence and correlates[br-m] of adult ADHD in the United States: results[br-m] from the national comorbidity survey[br-m] replication. Am J Psychiatry.[br-m] 2006;163(5):716-23.
- Danielson ML, et al. Prevalence of parent-[br-m]reported ADHD diagnosis and associated[br-m] treatment among U.S. children and[br-m] adolescents, 2016. J Clin Child Adolesc Psychol. 2018;47(2):199-212.
- Katzman MA, et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. 2017;17(1):302.
- Faraone SV, Larsson H. Genetics of attention[br-m] deficit hyperactivity disorder. Mol Psychiatry. 2019;24(4):562-575.
- da Silva BS, et al. An overview on neurobiology[br-m] and therapeutics of attention‑deficit/[br-m]hyperactivity disorder. Discov Ment Health. 2023;3(1):2.
24
24
0
false